Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1983 Jun;46(6):540–546. doi: 10.1136/jnnp.46.6.540

A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals.

T R Barnes, M Rossor, T Trauer
PMCID: PMC1027445  PMID: 6135761

Abstract

Oro-facial dyskinesia and purposeless trunk and limb movements were assessed, using a standard videotape rating technique, in 182 psychiatric patients receiving antipsychotic medication, in a second sample of 43 elderly psychiatric patients also receiving antipsychotic drugs, and 85 normal, drug-naive subjects. In both the first patient sample and the group of normal subjects, oro-facial dyskinesia was more common over 50 years of age. Statistical analysis of the data suggested that drug-induced oro-facial dyskinesia has a characteristic pattern of movement distribution significantly different from that of idiopathic oro-facial dyskinesia. The videotapes of the first patient sample and the normal subjects were viewed by a neurologist who assessed and categorised all movements. Purposeless trunk and limb movements were classified as either normal or abnormal. Normal purposeless movements were significantly more common in the drug-naive subjects. The presence of abnormal movements such as choreiform movements, dystonias and stereotypies and mannerisms was limited, almost exclusively, to the patients.

Full text

PDF
540

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altrocchi P. H. Spontaneous oral-facial dyskinesia. Arch Neurol. 1972 Jun;26(6):506–512. doi: 10.1001/archneur.1972.00490120046004. [DOI] [PubMed] [Google Scholar]
  2. Amsterdam J., Mendels J. Treatment-resistant tardive dyskinesia: a new therapeutic approach. Am J Psychiatry. 1979 Sep;136(9):1197–1198. doi: 10.1176/ajp.136.9.1197. [DOI] [PubMed] [Google Scholar]
  3. Barnes T. R., Trauer T. Reliability and validity of a tardive dyskinesia videotape rating technique. Br J Psychiatry. 1982 May;140:508–515. doi: 10.1192/bjp.140.5.508. [DOI] [PubMed] [Google Scholar]
  4. Blowers A. J., Borison R. L., Blowers C. M., Bicknell D. J. Abnormal involuntary movements in the elderly. Br J Psychiatry. 1981 Oct;139:363–364. [PubMed] [Google Scholar]
  5. Bobruff A., Gardos G., Tarsy D., Rapkin R. M., Cole J. O., Moore P. Clonazepam and phenobarbital in tardive dyskinesia. Am J Psychiatry. 1981 Feb;138(2):189–193. doi: 10.1176/ajp.138.2.189. [DOI] [PubMed] [Google Scholar]
  6. Bourgeois M., Boueilh P., Tignol J. Dyskinésies spontanées séniles idiopathiques et dyskinésies tardives des neuroleptiques. Enquête chez 270 vieillards. Encephale. 1980;6(1):37–39. [PubMed] [Google Scholar]
  7. Brandon S., McClelland H. A., Protheroe C. A study of facial dyskinesia in a mental hospital population. Br J Psychiatry. 1971 Feb;118(543):171–184. doi: 10.1192/bjp.118.543.171. [DOI] [PubMed] [Google Scholar]
  8. Burke R. E., Fahn S., Jankovic J., Marsden C. D., Lang A. E., Gollomp S., Ilson J. Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet. 1982 Jun 5;1(8284):1299–1299. doi: 10.1016/s0140-6736(82)92856-2. [DOI] [PubMed] [Google Scholar]
  9. Casey D. E., Denney D. Pharmacological characterization of tardive dyskinesia. Psychopharmacology (Berl) 1977 Aug 31;54(1):1–8. doi: 10.1007/BF00426532. [DOI] [PubMed] [Google Scholar]
  10. Casey D. E., Hammerstad J. P. Sodium valproate in tardive dyskinesia. J Clin Psychiatry. 1979 Nov;40(11):483–485. [PubMed] [Google Scholar]
  11. Casey D. E., Rabins P. Tardive dyskinesia as a life-threatening illness. Am J Psychiatry. 1978 Apr;135(4):486–488. doi: 10.1176/ajp.135.4.486. [DOI] [PubMed] [Google Scholar]
  12. Crane G. E., Naranjo E. R. Motor disorders induced by neuroleptics: a proposed new classification. Arch Gen Psychiatry. 1971 Feb;24(2):179–184. doi: 10.1001/archpsyc.1971.01750080083014. [DOI] [PubMed] [Google Scholar]
  13. Crane G. E. Persistent dyskinesia. Br J Psychiatry. 1973 Apr;122(569):395–405. doi: 10.1192/bjp.122.4.395. [DOI] [PubMed] [Google Scholar]
  14. Davis J. M. Dose equivalence of the antipsychotic drugs. J Psychiatr Res. 1974;11:65–69. doi: 10.1016/0022-3956(74)90071-5. [DOI] [PubMed] [Google Scholar]
  15. Delwaide P. J., Desseilles M. Spontaneous buccolinguofacial dyskinesia in the elderly. Acta Neurol Scand. 1977 Sep;56(3):256–262. doi: 10.1111/j.1600-0404.1977.tb01431.x. [DOI] [PubMed] [Google Scholar]
  16. Demars J. P. Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy. J Nerv Ment Dis. 1966 Jul;143(1):73–79. doi: 10.1097/00005053-196607000-00008. [DOI] [PubMed] [Google Scholar]
  17. Ellenor G. L. Reducing irrational antipsychotic polypharmacy prescribing. Hosp Pharm. 1977 Aug;12(8):369-71, 374-6. [PubMed] [Google Scholar]
  18. FAURBYE A., RASCH P. J., PETERSEN P. B., BRANDBORG G., PAKKENBERG H. NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES. Acta Psychiatr Scand. 1964;40:10–27. doi: 10.1111/j.1600-0447.1964.tb05731.x. [DOI] [PubMed] [Google Scholar]
  19. Fann W. E., Lake C. R., Gerber C. J., McKenzie G. M. Cholinergic suppression of tardive dyskinesia. Psychopharmacologia. 1974 Jun 21;37(4):101–107. doi: 10.1007/BF00437417. [DOI] [PubMed] [Google Scholar]
  20. Gardos G., Cole J. O., La Brie R. The assessment of tardive dyskinesia. Arch Gen Psychiatry. 1977 Oct;34(10):1206–1212. doi: 10.1001/archpsyc.1977.01770220088010. [DOI] [PubMed] [Google Scholar]
  21. Gardos G., Cole J. O., Sniffin C. An evaluation of papaverine in tardive dyskinesia. J Clin Pharmacol. 1976 May-Jun;16(5-6):304–310. doi: 10.1002/j.1552-4604.1976.tb02409.x. [DOI] [PubMed] [Google Scholar]
  22. Gerlach J. Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism. Psychopharmacology (Berl) 1977 Mar 16;51(3):259–263. doi: 10.1007/BF00431633. [DOI] [PubMed] [Google Scholar]
  23. Granacher R. P., Jr Differential diagnosis of tardive dyskinesia: an overview. Am J Psychiatry. 1981 Oct;138(10):1288–1297. doi: 10.1176/ajp.138.10.1288. [DOI] [PubMed] [Google Scholar]
  24. Greenblatt D. L., Dominick J. R., Stotsky B. A., DiMascio A. Phenothiazine-induced dyskinesia in nursing-home patients. J Am Geriatr Soc. 1968 Jan;16(1):27–34. doi: 10.1111/j.1532-5415.1968.tb03966.x. [DOI] [PubMed] [Google Scholar]
  25. Hippius H., Lange J. Zur Problematik der späten extrapyramidalen Hyperkinesen nach langfristiger neuroleptischer Therapie. Arzneimittelforschung. 1970 Jul;20(7):888–890. [PubMed] [Google Scholar]
  26. Kennedy P. F., Hershon H. I., McGuire R. J. Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry. 1971 May;118(546):509–518. doi: 10.1192/bjp.118.546.509. [DOI] [PubMed] [Google Scholar]
  27. Kidger T., Barnes T. R., Trauer T., Taylor P. J. Sub-syndromes of tardive dyskinesia. Psychol Med. 1980 Aug;10(3):513–520. doi: 10.1017/s0033291700047401. [DOI] [PubMed] [Google Scholar]
  28. Klawans H. L., Bergen D., Bruyn G. W., Paulson G. W. Neuroleptic-induced tardiave dyskinesias in nonpsychotic patients. Arch Neurol. 1974 Apr;30(4):338–339. doi: 10.1001/archneur.1974.00490340066018. [DOI] [PubMed] [Google Scholar]
  29. Pryce I. G., Edwards H. Persistent oral dyskinesia in female mental hospital patients. Br J Psychiatry. 1966 Oct;112(491):983–987. doi: 10.1192/bjp.112.491.983. [DOI] [PubMed] [Google Scholar]
  30. Rosen A. M., Mukherjee S., Olarte S., Varia V., Cardenas C. Perception of tardive dyskinesia in outpatients receiving maintenance neuroleptics. Am J Psychiatry. 1982 Mar;139(3):372–374. doi: 10.1176/ajp.139.3.372. [DOI] [PubMed] [Google Scholar]
  31. Siede H., Müller H. F. Choreiform movements as side effects of phenothiazine medication in geriatric patients. J Am Geriatr Soc. 1967 Jun;15(6):517–522. doi: 10.1111/j.1532-5415.1967.tb01191.x. [DOI] [PubMed] [Google Scholar]
  32. Simpson G. M., Voitashevsky A., Young M. A., Lee J. H. Deanol in the treatment of tardive dyskinesia. Psychopharmacology (Berl) 1977 May 9;52(3):257–261. doi: 10.1007/BF00426709. [DOI] [PubMed] [Google Scholar]
  33. Smith J. M., Baldessarini R. J. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry. 1980 Dec;37(12):1368–1373. doi: 10.1001/archpsyc.1980.01780250054006. [DOI] [PubMed] [Google Scholar]
  34. Tepper S. J., Haas J. F. Prevalence of tardive dyskinesia. J Clin Psychiatry. 1979 Dec;40(12):508–516. [PubMed] [Google Scholar]
  35. Wyatt R. J., Torgow J. S. A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders. J Psychiatr Res. 1977;13(2):91–98. doi: 10.1016/0022-3956(77)90011-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES